Literature DB >> 6115806

Effects of cimetidine and ranitidine on gastric transmural potential difference and on prolactin secretion in man.

D von Kleist, K J Gräf, F C Dougherty, K E Hampel.   

Abstract

Endoscopically controlled measurement of gastric mucosal potential differences was performed in 50 subjects receiving ranitidine, cimetidine or normal saline. Significant maximum potential increases were recorded within 15 min of bolus injections of ranitidine in doses of 20 and 40 mg and cimetidine (200 and 400 mg). Under these conditions, ranitidine proved to be 12 times more potent than cimetidine, compared on a molar basis. There was a dose-related increase in serum prolactin concentration within 15 min of injection of 200 and 400 mg of cimetidine, while injections of 20 and 40 mg of ranitidine failed to enhance prolactin secretion. It would appear that the stimulatory effect of cimetidine on serum prolactin concentration is not mediated through its histamine H2-receptor antagonist activity.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6115806

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  6 in total

1.  Plasma prolactin, sex steroids and gastrin in human volunteers treated for 2 weeks with therapeutic doses of cimetidine or the new histamine H2-receptor antagonist ramixotidine (CM 57755A).

Authors:  M Colle; E Ruedas; J Cazenave; J Auzerie; G Basilisco; G Camboni; L Manara
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

Review 2.  Famotidine. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in peptic ulcer disease and other allied diseases.

Authors:  H D Langtry; S M Grant; K L Goa
Journal:  Drugs       Date:  1989-10       Impact factor: 9.546

Review 3.  Ranitidine: a review of its pharmacology and therapeutic use in peptic ulcer disease and other allied diseases.

Authors:  R N Brogden; A A Carmine; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1982-10       Impact factor: 9.546

4.  Diflunisal protects human gastric mucosa against damage by indomethacin.

Authors:  M M Cohen
Journal:  Dig Dis Sci       Date:  1983-12       Impact factor: 3.199

5.  Ranitidine compared with cimetidine in the short-term healing of duodenal ulcer.

Authors:  F I Lee; J D Fielding; F T Costello
Journal:  Postgrad Med J       Date:  1983-02       Impact factor: 2.401

Review 6.  Famotidine. Pharmacodynamic and pharmacokinetic properties and a preliminary review of its therapeutic use in peptic ulcer disease and Zollinger-Ellison syndrome.

Authors:  D M Campoli-Richards; S P Clissold
Journal:  Drugs       Date:  1986-09       Impact factor: 9.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.